To compare industry payments from drug and medical device companies to urologists and urologic advanced practice providers (APPs) in 2021.
We used the 2020 Medicare Data on Provider Practice and Specialty file to identify single-specialty urology practices, defined as those where the majority of physicians were urologists. We then used the Open Payments Program Year 2021 data to summarize the value and number of industry payments to urologists and APPs, including nurse practitioners (NPs) and physician assistants (PAs), in these practices. We calculated the total value and number of payments and median total value and number of payments per provider for urologists and urologic APPs.
We identified 4,418 urologists and 1,099 APPs working in single-specialty urology practices in 2021 (Table 1). Of these, 3,646 (87%) urologists received at least one industry payment, totaling $14,755,003 from 116,039 payments, and 954 urologic APPs (87%) received at least one industry payment, including 463 NPs (85%), totaling $401,283 from 13,035 payments, and 491 PAs (89%), totaling $543,429 from 14,626 payments. We observed significantly greater median total value and number of payments per provider for urologists ($620 and 24 payments) compared to urologic APPs ($473 and 21 payments; p<0.001 and p=0.017, respectively).
A similar percentage of urologists and urologic APPs received industry payments in 2021. While urologists received a higher total number and total value of payments in 2021, urologic APPs were a common target of industry marketing payments.

Copyright © 2023 Elsevier Inc. All rights reserved.